Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Circulatory

  • News

    Apixaban is safest effective DOAC for stroke prevention in Afib, per AHRQ report

    November 10, 2018

    The agency found the lowest bleeding risk with apixaban, but cites lack of head-to-head trials as a limitation in evaluating DOACs.

  • 1
    News

    CT opens extended window for stroke thrombolysis

    November 1, 2018

    MONTREAL – The new EXTEND findings “will have a major impact” on using an extended time window for thrombolysis in U.S. practice.

  • 1
    Article

    EHR-guided strategy reduces postop VTE events

    October 27, 2018

    BOSTON – Missed doses of enoxaparin correlate with increased incidence of deep vein thrombosis.

  • 1
    News

    VTE risk after gynecologic surgery lower with laparoscopic procedures

    October 26, 2018

    Laparoscopic and vaginal gynecologic surgery are associated with a lower incidence of postoperative VTE, compared with laparotomy.

  • 1
    News

    Stroke risk in elderly following AMI extends to 12 weeks

    October 24, 2018

    ATLANTA – The prolonged period of heightened risk was evident in patients with both STEMI and NSTEMI.

  • 1
    News

    Readmission to non-index hospital following acute stroke linked to worse outcomes

    October 22, 2018

    ATLANTA – Study adds to the stroke literature on nationwide estimates of 30-day readmissions.

  • 1
    News

    DAPT’s benefit after stroke or TIA clusters in first 21 days

    October 19, 2018

    MONTREAL – The superiority of clopidogrel plus aspirin over aspirin alone was apparent only during the first 21 days of treatment.

  • 1
    News

    Be proactive with prophylaxis to tame VTE

    October 12, 2018

    Dr. Jeffrey Weitz offers seven steps to improve prophylaxis in the hospital.

  • 1
    News

    CT for evaluating pulmonary embolism overused

    October 12, 2018

    SAN ANTONIO – Computed tomography may be is overused for evaluation of pulmonary embolism.

  • 1
    News

    GARFIELD-AF registry: DOACs cut mortality 19%

    October 10, 2018

    MUNICH – Results from a worldwide registry with more than 26,000 atrial fibrillation patients showed better survival with a direct oral anticoagulant.

Previous1 … 12 13 14 15 16 … 25Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences